1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Acadia Healthcare entered a new credit agreement with JPMorgan Chase Bank as administrative agent, providing a $1 billion revolving facility and a $650 million term loan, both maturing February 28, 2030. The company used the proceeds to refinance obligations under its prior credit agreement, which it terminated, and the new facilities carry floating interest rates and financial covenants.
New $1 billion revolving facility and $650 million term loan, both maturing February 28, 2030
Proceeds used to refinance obligations under the Existing Credit Agreement, which was dated March 17, 2021 and scheduled to mature March 17, 2026
Borrowings bear floating rates: SOFR plus 1.375% to 2.250%, or base rate plus 0.375% to 1.250%, based on net leverage
Covenants include a Consolidated Total Net Leverage Ratio of no more than 5.0 to 1.0 and Interest Coverage of at least 3.0 to 1.0
ABM Industries entered an amended and restated credit agreement dated February 26, 2025, with Bank of America as administrative agent. The facility provides $1.6 billion of revolving commitments and $600 million of term facility commitments, both with a five-year term maturing February 26, 2030, and it refinances the company's prior credit agreement from 2017.
Revolving credit commitments of $1.6 billion and term facility commitments of $600 million, maturing February 26, 2030
Borrowings priced at a margin tied to the total net leverage ratio over Term SOFR or a base rate; commitment fee of 0.200% to 0.400%
Financial covenants include maximum total net leverage of 5.00 to 1.00, maximum secured net leverage of 4.00 to 1.00, and minimum interest coverage of 1.50 to 1.00
Initial term loan proceeds were used to refinance the Original Credit Agreement, repay part of revolving borrowings and pay transaction costs
Emerson agreed on February 25, 2025 to sell €500 million of 3.000% notes due 2031, €500 million of 3.500% notes due 2037, and $500 million of 5.000% notes due 2035, with closing expected March 4, 2025. The company expects net proceeds of about $1,536.7 million, to be used for general corporate purposes, commercial paper repayment, and part of the purchase price for its proposed acquisition of AspenTech; the filing notes the notes offering is not conditioned on that acquisition closing.
Euro notes: €500 million 3.000% due 2031 sold at 99.561% of principal and €500 million 3.500% due 2037 sold at 99.270%.
Dollar notes: $500 million 5.000% due 2035 sold at 99.454% of principal.
Expected net proceeds of about $1,536.7 million, before offering expenses, with closing expected March 4, 2025.
Proceeds partly fund the proposed purchase of AspenTech shares not already owned by Emerson, which the filing says may not be completed on the anticipated terms or at all.
Gen Digital issued $950 million of 6.250% Senior Notes due 2033 on February 28, 2025, in a private offering. The company said it used the proceeds, along with cash on hand, to repurchase all of its outstanding 5.00% Senior Notes due 2025 and pay accrued interest on them. The filing describes a refinancing that replaces near-term debt with notes maturing in 2033, though it does not report a change in total debt.
Notes: $950 million principal, 6.250% annual interest, paid semi-annually, maturing April 1, 2033
Interest payments begin October 1, 2025; the company may redeem some notes before April 1, 2028 at a make-whole price
Proceeds plus cash on hand used to repurchase all outstanding 5.00% Senior Notes due 2025
Notes sold only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S
The Cheesecake Factory issued $575 million of 2.00% convertible senior notes due March 15, 2030, including $75 million from the full exercise of the initial purchasers' option. The company's press release says it plans to use part of the net proceeds to repurchase $276 million of its 0.375% convertible notes due 2026 and about 2.4 million common shares, which may affect the trading price of its stock and the initial conversion price.
Notes issued February 28, 2025: $575 million principal, including $75 million from the full exercise of the initial purchasers' option; interest is payable semi-annually beginning September 15, 2025.
Initial conversion price is about $70.73 per share, a premium of about 30.0% over the $54.41 closing price on February 25, 2025; up to 10,567,868 shares may be issued on conversion at the maximum conversion rate.
Press release estimates net proceeds of about $558.5 million with the option fully exercised; about $290.0 million is earmarked to repurchase $276.0 million of 2026 notes and about $130.0 million to repurchase about 2.4 million shares.
Targa Resources Corp. completed a $2.0 billion underwritten offering of senior notes due 2035 and 2055, each $1.0 billion. The company expects to use part of the proceeds to repurchase the outstanding preferred equity in Targa Badlands LLC, which holds its North Dakota assets, for about $1.8 billion in cash. For shareholders, this is a large debt-funded transaction that adds long-term borrowing while buying out a joint venture partner's stake.
$1.0 billion of 5.550% Senior Notes due 2035 and $1.0 billion of 6.125% Senior Notes due 2055 were issued on February 27, 2025.
Proceeds are expected to fund a roughly $1.8 billion cash repurchase of joint venture partner's preferred equity in Targa Badlands LLC, expected to close in the first quarter of 2025.
If the Badlands transaction does not close, proceeds will go to general corporate purposes, including repaying commercial paper borrowings.
Astrana Health entered an amended and restated credit agreement on February 26, 2025, with Truist Bank as agent and a group of lenders. The facilities total $1.295 billion, including a $745 million delayed draw term loan to finance an acquisition under a November 8, 2024 purchase agreement with Prospect Medical Holdings. The new debt terms replace the company's 2021 credit agreement and carry leverage and interest coverage covenants, plus a security interest in the company's assets.
Revolving credit facility of $300 million, term loan A of $250 million and delayed draw term loan of $745 million, all five-year facilities
Delayed draw term loan funds an asset and equity acquisition from Prospect Medical Holdings, Inc. under an agreement dated November 8, 2024
Interest rate spreads of 1.25% to 2.50% over term SOFR, set quarterly by leverage ratio; covenants require maximum net leverage of 5.00 to 1.00, stepping down to 4.50 to 1.00 after March 31, 2027, and minimum interest coverage of 2.50 to 1.
Separate 2025 Annual Meeting of Stockholders set for June 11, 2025, held virtually, with a record date of April 22, 2025
On February 26, 2025, D.R. Horton completed a public offering of $700 million in 5.500% senior notes maturing October 15, 2035, receiving net proceeds of $695.2 million after the underwriting discount. The notes are guaranteed by substantially all of the company's current homebuilding subsidiaries and rank as general unsecured obligations. The filing adds $700 million of debt, which shareholders may weigh against the company's existing borrowings.
Principal amount: $700 million of 5.500% senior notes due October 15, 2035
Net proceeds after underwriting discount: $695.2 million
Interest payable semi-annually on April 15 and October 15, beginning October 15, 2025
Change of control plus ratings downgrade triggers an offer to repurchase at 101% of principal
On February 26, 2025, XPO entered into a refinancing amendment that provides new term loan B facilities of up to $700 million and $400 million to repay its existing term loans, and a new $600 million revolving credit agreement with Wells Fargo that replaced its former ABL revolving credit facility. The company terminated all obligations under the former ABL facility on the same date. The new debt is secured by substantially all company and guarantor assets and carries covenants that could trigger defaults if breached.
Term loan B-2 facility of up to $700 million matures May 24, 2028
Term loan B-3 facility of up to $400 million matures February 1, 2031
New $600 million revolving credit facility, including $200 million for letters of credit, matures April 30, 2030
Former ABL credit agreement dated October 30, 2015 was terminated on February 26, 2025
Camden Property Trust established a commercial paper program on February 25, 2025, allowing it to issue short-term unsecured notes with total outstanding principal capped at $600 million. No notes were outstanding under the program at filing, and proceeds are expected for general corporate purposes including property acquisitions and development.
Program cap: aggregate outstanding notes not to exceed $600 million at any time
Notes mature in up to 397 days from issue and rank at least pari passu with other unsecured debt
No notes were outstanding under the program as of the filing
Program established February 25, 2025; filed February 26, 2025
Selective Insurance Group issued $400 million of 5.900% senior notes due April 15, 2035, under an underwriting agreement with Goldman Sachs, BofA Securities and Wells Fargo Securities as representatives. The filing describes new debt the company must repay with interest, which adds to its financial obligations, but it does not report earnings or other operating results.
Principal amount: $400 million of 5.900% Senior Notes due April 15, 2035
Interest payable semi-annually on April 15 and October 15, starting October 15, 2025
Company may redeem before January 15, 2035 at a make-whole price; at par plus accrued interest on or after that date
Rollins, Inc. issued $500 million of 5.25% senior unsecured notes maturing February 24, 2035, under an indenture dated February 24, 2025. The company said it will mainly use the proceeds to repay borrowings under its $1.0 billion revolving credit facility, with the rest for general corporate purposes. The debt adds a fixed-rate obligation that shareholders should weigh against the company's existing borrowings.
Notes: $500 million aggregate principal, 5.25% annual interest paid semiannually, first payment August 24, 2025
Maturity February 24, 2035; redeemable before November 24, 2034 with a make-whole premium
Proceeds mainly to repay Credit Facility borrowings; notes rank equally with other senior debt, including the Credit Facility
Registration rights agreement requires an exchange offer filing within 270 days; interest rate rises 0.25% if deadlines are missed
AutoNation closed on February 24, 2025, its sale of $500 million in 5.890% senior notes maturing March 15, 2035, issued at 99.995% of principal. The company adds $500 million of long-term debt, and the notes are not guaranteed by its subsidiaries, which means they rank behind subsidiary liabilities, including trade payables.
Principal amount: $500 million; issued at 99.995% of principal, a yield to maturity of 5.890%
Maturity date March 15, 2035; interest paid semiannually on March 15 and September 15, starting September 15, 2025
Notes are not guaranteed by subsidiaries and are structurally subordinated to subsidiary liabilities
Indenture limits liens, sale and leaseback transactions, and mergers or asset transfers; underwriters are BofA Securities, J.P. Morgan, Mizuho, Truist and Wells Fargo
Tanger Inc. entered a new at-the-market program allowing it to sell up to $400 million of common shares through sales agents, at times and amounts it chooses. The program replaces a prior $250 million program, which was terminated with $34.5 million of remaining capacity, though outstanding forward sales from that program remain in effect until settled. Share sales would add to the outstanding share count, so the program matters to existing shareholders, though the company has no obligation to sell any shares.
New at-the-market program covers up to $400 million of common shares, with sales agents paid up to 2.0% of gross sales price.
Prior $250 million program was terminated on February 24, 2025, retiring $34.5 million of remaining capacity.
Outstanding forward sales of 1,915,762 shares ($69,730,795 gross) from the 2023 program have outside settlement dates of December 31, 2025 and March 31, 2026.
Company intends to use net proceeds for general corporate purposes, including property acquisitions, expansions and debt repayment.
On February 21, 2025, Marina Bay Sands, a subsidiary of Las Vegas Sands, entered a Singapore credit agreement with DBS Bank as agent, providing three facilities: a SGD 3.75 billion term loan (about $2.81 billion), a SGD 750 million revolver (about $561 million) and a SGD 7.5 billion delayed draw term loan (about $5.61 billion) tied to the Marina Bay Sands expansion. The company also notified DBS on February 18, 2025 that it intends to prepay its 2012 Singapore credit facility, conditional on receiving proceeds from the new facilities, so the filing mainly reflects a refinancing and new borrowing capacity for shareholders to weigh.
Term Loan Facility of SGD 3.75 billion (about $2.81 billion) is available for 30 days after the February 21, 2025 execution date
Delayed Draw Term Loan Facility of SGD 7.5 billion (about $5.61 billion) funds Marina Bay Sands expansion development and construction costs
Obligations are secured by a first-priority security interest in substantially all of the borrower's assets, with maximum leverage and minimum interest coverage covenants
Term Loan Facility matures 84 months and Revolving Facility 78 months after the Closing Date; prepayment of the 2012 facility is conditioned on these proceeds
On February 18, 2025, L3Harris entered a new $2.5 billion, five-year senior unsecured revolving credit facility with JPMorgan Chase Bank as administrative agent, replacing its prior $2 billion facility from July 29, 2022, which the company says incurred no early termination penalties. The company also set up a new $500 million, 364-day revolving facility to replace a $1.5 billion facility that matured on January 24, 2025. The filing describes the terms of these refinancings and does not state any amounts drawn under them, and the excerpt ends partway through Item 2.03.
New $2.5 billion revolver matures February 18, 2030, with a possible one-year extension under certain circumstances.
Prior $2 billion facility dated July 29, 2022 was terminated; the filing says no early termination penalties were incurred.
New $500 million 364-day facility commitments run through February 17, 2026, replacing a $1.5 billion facility that matured January 24, 2025.
Initial interest margin on the $2.5 billion facility is 1.125% over term SOFR, adjustable based on L3Harris senior debt ratings.
Eastman Chemical issued $250 million of 5.000% notes due August 1, 2029, in a public offering, adding to $500 million of the same notes issued in August 2024. The company expects net proceeds of about $246.2 million for general corporate purposes, including working capital, capital expenditures and debt repayment.
Notes: $250 million principal, 5.000% coupon, maturing August 1, 2029, issued February 21, 2025
Expected net proceeds of approximately $246.2 million after underwriting discounts and offering expenses
Underwriting Agreement dated February 18, 2025, with BofA Securities and J.P. Morgan Securities as representatives
Notes form a single series with the $500 million of 5.000% notes issued August 1, 2024
On February 19, 2025, Molina Healthcare entered a third amendment to its credit agreement with Truist Bank as administrative agent, which amends and restates the prior agreement dated June 8, 2020. The amendment adds a $500 million delayed draw commitment that can be drawn for general corporate purposes if the company meets pro forma financial covenants. For shareholders, this adds committed borrowing capacity, though the filing does not say whether any amount has been drawn.
Third amendment dated February 19, 2025, with Truist Bank as administrative agent; prior agreement dated June 8, 2020
$500 million delayed draw commitment, available until June 19, 2025, with a maturity date of February 19, 2027
Applicable margin of 0.125% for base rate loans and 1.125% for SOFR-based loans; ticking fee of 0.25% per annum on the unused commitment
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $5.25 billion in senior notes on February 21, 2025, across six tranches maturing between 2028 and 2055. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, and the filing adds $5.25 billion of direct financial obligations to the company's debt.
Six tranches total $5.25 billion: $700 million 5.000% notes due 2028, $300 million floating rate notes due 2028, $750 million 5.250% notes due 2030, $750 million 5.500% notes due 2032, $1.5 billion 5.750% notes due 2035 and $1.25 billion 6.
Interest on the fixed-rate notes is payable semi-annually on March 1 and September 1, starting September 1, 2025
The notes were sold under a shelf registration filed May 1, 2023, with underwriters including BofA Securities, Barclays and J.P. Morgan, under an underwriting agreement dated February 18, 2025
Exelon sold $1.0 billion of senior notes on February 21, 2025, split into $500 million of 5.125% notes due 2031 and $500 million of 5.875% notes due 2055. Part of the proceeds, with available cash, will repay $464 million of commercial paper borrowings that carried a weighted average rate of 4.537% as of February 11, 2025, and the rest will fund general corporate purposes. The filing describes a financing transaction that adds long-term debt rather than a change to operations or earnings.
Notes: $500 million of 5.125% due March 15, 2031 and $500 million of 5.875% due March 15, 2055
Interest paid semi-annually on March 15 and September 15, starting September 15, 2025
$464 million of proceeds plus cash on hand to repay commercial paper at about 4.537% weighted average rate
Mondelez entered into two new unsecured revolving credit agreements on February 19, 2025, totaling $6.0 billion, and terminated its existing $1.5 billion 364-day and $4.5 billion five-year facilities. The company said it will use the new facilities for general corporate purposes, including working capital and support for its commercial paper program. Both agreements require minimum shareholders' equity of at least $25.0 billion.
New 364-day facility: $1.5 billion, terminating February 18, 2026, replacing a facility dated February 21, 2024
New five-year facility: $4.5 billion, terminating February 19, 2030 unless extended, replacing a facility dated February 23, 2022
Both facilities require minimum shareholders' equity of not less than $25.0 billion and carry JPMorgan Chase Bank, N.A. as administrative agent
Leidos subsidiary Leidos, Inc. sold $1 billion of senior unsecured notes in two $500 million tranches, due 2032 (5.400%) and 2035 (5.500%). Proceeds are planned for a tender offer for 3.625% notes due 2025, share repurchases, a partial term loan paydown, potential acquisitions and fees.
Two $500 million tranches: 5.400% notes due March 15, 2032 and 5.500% notes due March 15, 2035
Proceeds intended for tender offer of 3.625% notes due 2025, term loan repayment, share repurchases and potential acquisitions
Notes are guaranteed by Leidos Holdings, Inc.; interest is payable semi-annually from September 15, 2025
Holders can require repurchase at 101% of principal upon a change of control triggering event
ONEOK entered a second amended and restated credit agreement on February 14, 2025, with Citibank as administrative agent. The $3.5 billion unsecured revolving facility replaces the prior $2.5 billion facility and extends maturity from June 2028 to February 2030. Subsidiaries ONEOK Partners, Magellan, and EnLink guaranteed the obligations, which matters to shareholders because it expands the company's committed borrowing capacity and extends its debt maturity profile.
Facility size increased from $2.5 billion to $3.5 billion; ONEOK may request up to an additional $1.0 billion in commitments.
Maturity extended from June 2028 to February 2030, with the term running five years from the February 14, 2025 closing date.
Covenant requires a net leverage ratio not to exceed 5.00:1.00, stepping up to 5.50:1.00 for two fiscal quarters after an acquisition over $25 million.
Guarantors include ONEOK Partners, L.P., ONEOK Partners Intermediate Limited Partnership, Magellan Midstream Partners, L.P., and EnLink Midstream Partners, LP, all wholly owned subsidiaries.
RenaissanceRe Holdings agreed on February 18, 2025 to sell $500 million of 5.800% senior notes due 2035 in an underwritten public offering. The company expects the offering to close on or about February 25, 2025, and plans to use the net proceeds for general corporate purposes, which may include redeeming, repaying or refinancing certain indebtedness.
Offering size: $500 million aggregate principal amount of 5.800% Senior Notes due 2035
Expected closing: on or about February 25, 2025, subject to customary conditions
On February 14, 2025, Nextracker and its subsidiary Nextracker LLC amended their Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment replaces the $1.0 billion basket for surety bonds with an unlimited amount when the pro forma Total Net Leverage Ratio does not exceed 2.75:1.00, and 200% of Consolidated EBITDA when it does. On February 19, 2025, the borrower repaid the term loan under the Credit Agreement in full. The filing does not state the term loan amount, so shareholders can see the change in borrowing capacity but not its size.
Surety bond basket was previously $1.0 billion; amended basket is unlimited if pro forma Total Net Leverage Ratio does not exceed 2.75:1.00
If the ratio exceeds 2.75:1.00, surety bonds are capped at 200% of Consolidated EBITDA
Amendment dated February 14, 2025, to the Credit Agreement dated February 13, 2023
Term loan repaid in full on February 19, 2025; the filing does not disclose the amount
Zimmer Biomet completed the issuance of $600 million of 4.700% notes due 2027, $550 million of 5.050% notes due 2030 and $600 million of 5.500% notes due 2035, adding $1.75 billion of direct debt. The 2030 and 2035 notes must be redeemed at 101% of principal, plus accrued interest, if the pending Paragon 28 acquisition is not completed on time or is terminated, so their repayment depends on that deal.
The 2027 notes mature February 19, 2027, the 2030 notes February 19, 2030 and the 2035 notes February 19, 2035.
Interest is payable semi-annually on February 19 and August 19, starting August 19, 2025.
The 2030 and 2035 notes carry a special mandatory redemption at 101% of principal if the Paragon 28 merger is not completed by November 28, 2025 (extendable to January 28, 2026) or the merger agreement is terminated.
The notes were issued under a Twelfth Supplemental Indenture dated February 19, 2025, to a base indenture dated November 17, 2009, with Computershare Trust Company, N.A. as trustee.
On February 13, 2025, MPT's operating partnership closed $1.5 billion of 8.500% notes due 2032 and €1.0 billion of 7.000% notes due 2032, and the company amended its revolving credit and term loan agreement. The notes are secured by first-priority liens on equity of subsidiaries owning or ground leasing 169 properties, and the amendment extends the revolving facility's maturity to June 30, 2027 while removing several financial covenants and resetting the interest rate to SOFR plus 2.25%. The filing shows new secured debt ranking alongside the credit facility, which may affect how much collateral is available to unsecured creditors and shareholders.
$1.5 billion of 8.500% Senior Secured Notes due February 15, 2032 and €1.0 billion of 7.000% Senior Secured Notes due 2032 were issued under an indenture dated February 13, 2025.
Notes are secured by first-priority liens on equity of subsidiaries that own or ground lease 169 properties with 20 operators in the United States, United Kingdom and Germany.
Amendment No. 3 extends the revolving credit facility maturity to June 30, 2027, resets interest to SOFR plus 2.25% and sets a maximum secured leverage ratio of 40%.
Before February 15, 2028, up to 40% of each note series may be redeemed at 108.500% (dollar notes) or 107.000% (euro notes) using equity offering proceeds.
Aramark Services, Inc., an indirect wholly owned subsidiary of Aramark, entered into Incremental Amendment No. 17 to its credit agreement on February 18, 2025, establishing $1,395,000,000 of new U.S. Term B-8 Loans due June 2030. The proceeds were used to refinance the U.S. Term B-4 Loans, redeem the company's 5.000% Senior Notes due 2025, and pay related fees and costs. The filing describes a refinancing of existing debt rather than new borrowing for an acquisition or other stated purpose.
New U.S. Term B-8 Loans totaling $1,395,000,000, fungible with existing B-8 loans due June 2030
Loans bear interest at Term SOFR or a base rate, plus a margin of 2.00% (Term SOFR) or 1.00% (base rate)
Proceeds refinanced U.S. Term B-4 Loans and redeemed the 5.000% Senior Notes due 2025
Quarterly principal installments begin March 31, 2025, with a balloon payment of $2,346,397,208.12 at maturity
On February 18, 2025, Essex Portfolio, L.P., the operating partnership of Essex Property Trust, Inc., issued $400.0 million of 5.375% senior notes due April 1, 2035, with the parent company guaranteeing them. Net proceeds were approximately $395.5 million, which the filing says are intended mainly to repay debt maturities, including part of $500.0 million of 3.500% notes due April 2025.
Notes issued at 99.604% of principal, with semi-annual interest payments starting October 1, 2025
Proceeds of approximately $395.5 million after underwriting discount and offering expenses, partly earmarked for repaying $500.0 million of 3.500% notes due April 2025
Exhibit index describes the form of notes as 5.500% due 2034, which differs from the 5.375% due 2035 in the filing text
Emerson entered a $3 billion 364-day credit agreement on February 11, 2025, with JPMorgan Chase as agent, to back its commercial paper and support a planned tender offer for Aspen Technologies shares. The company says it has no outstanding loans under the facility and no current plan to borrow, and it separately reported a shareholder-approved amendment reducing supermajority voting requirements for preferred stock terms.
$3 billion 364-day credit facility dated February 11, 2025, expires February 10, 2026
No outstanding loans or letters of credit under the facility; no borrowings under this or prior similar facilities
Facility serves as liquidity back-up for commercial paper, which will be expanded to help finance the planned Aspen Technologies tender offer
Shareholders approved amendment to Restated Articles of Incorporation on February 4, 2025; effective February 10, 2025
Federal Realty Investment Trust amended its equity distribution agreement, raising the aggregate offering price of common shares that may be sold to $750 million as of February 14, 2025. The company also approved a modified compensation package for its CFO, Daniel Guglielmone, on February 12, 2025.
Share sales program capacity raised to $750 million as of February 14, 2025, from $500 million effective March 8, 2024.
Under the prior $500 million amount, 3,183,181 shares were sold for an aggregate $355,592,783.
Guglielmone's approved terms: $650,000 base salary, annual bonus target of 150% of base salary, and $1,500,000 annual long-term incentive target.
ARMOUR Residential REIT amended its equity sales agreement to raise the number of common shares it may sell through agents by 15,000,000. The amended program covers up to 24,049,403 shares, including 9,049,403 shares left unsold under earlier amendments. The filing does not state how many shares have been sold or the proceeds, and it describes the change only as a sales program expansion, so existing shareholders may face potential dilution if these shares are issued.
Amendment No. 5 dated February 13, 2025 adds 15,000,000 shares to the at-the-market sales program
Total shares available under the amended agreement: 24,049,403, including 9,049,403 unsold shares carried over
Sales agents include BUCKLER Securities, B. Riley Securities, BTIG, Citizens JMP, Janney Montgomery Scott, JonesTrading, Ladenburg Thalmann and StockBlock Securities
Shares will be issued under a prospectus supplement filed February 13, 2025 on shelf registration Form S-3 (No. 333-278327)
On February 13, 2025, Alexandria Real Estate Equities, Inc. issued and sold $550 million of 5.50% Senior Notes due October 1, 2035, in a registered public offering. The notes are unsecured senior obligations, fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P., and rank equally with the company's existing and future unsecured senior debt. The filing adds new long-term debt for shareholders to weigh, and it does not discuss the use of proceeds.
$550 million aggregate principal of 5.50% Senior Notes issued February 13, 2025, maturing October 1, 2035
Interest is payable semi-annually on April 1 and October 1, beginning October 1, 2025
Notes may be redeemed before July 1, 2035 at par plus accrued interest and a make-whole amount; U.S. Bank Trust Company, National Association is trustee
Vontier and certain subsidiaries signed amendments dated February 12, 2025, creating a three-year, $500 million senior unsecured term loan maturing February 12, 2028, and a five-year, $750 million senior unsecured revolving credit facility maturing February 12, 2030, with Bank of America as agent. The filing sets borrowing costs that depend on Vontier's long-term debt credit rating and extends the maturities of its existing credit agreements, but it does not state how much has been borrowed.
Term loan: three-year, $500 million, maturing February 12, 2028; Term SOFR plus 0.875% to 1.500% or Base Rate plus 0% to 0.500%
Revolving credit facility: five-year, $750 million, maturing February 12, 2030, including a $25 million swingline sublimit and a $75 million letter of credit sublimit
Revolver pricing: Term SOFR plus 1.015% to 1.575% or Base Rate plus 0.015% to 0.575%, depending on credit rating; agreements filed as Exhibits 10.1 and 10.2
PennyMac Mortgage Investment Trust closed an underwritten offering of $172.5 million in 9.00% Senior Notes due 2030 on February 11, 2025, including $22.5 million from the underwriters' full exercise of their over-allotment option. The notes add fixed-rate debt that the company must repay with interest, and they are guaranteed by subsidiary PennyMac Corp.
Notes carry a 9.00% annual interest rate, paid quarterly, with the first payment on May 15, 2025, and maturity on February 15, 2030.
The company may redeem the notes at 100% of principal plus accrued interest on or after February 15, 2027, on at least 30 days' notice.
On a change of control, holders can require repurchase at 101% of principal plus accrued interest.
The notes are approved for listing on the New York Stock Exchange under the symbol PMTV, with trading expected within 30 days.
Toll Brothers extended the maturity dates of its revolving credit facility and its $650 million term loan to February 7, 2030, and increased the revolver's total commitments from $1.955 billion to $2.35 billion. The filing describes these as changes made under the existing terms of the agreements, with no other provisions modified, which gives the company longer-dated borrowing capacity.
Revolving credit agreement maturity extended from February 14, 2028 to February 7, 2030
Revolving commitments increased from $1.955 billion to $2.35 billion
All $650 million of outstanding term loan maturities extended to February 7, 2030
Registrant and substantially all 100% owned home building subsidiaries guarantee both facilities
On February 4, 2025, Phillips Edison & Company and its operating partnership entered into first amendments to three credit agreements with Bank of America, KeyBank and Capital One. Each amendment makes conforming changes tied to earlier amendments to the company's credit agreement with PNC Bank, and the filing gives no new borrowing amounts, rates or terms.
Bank of America Amendment amends the Second Amended and Restated Credit Agreement dated July 31, 2023 (Exhibit 10.1)
KeyBank Amendment amends the Amended and Restated Credit Agreement dated July 31, 2023 (Exhibit 10.2)
Capital One Amendment amends the Amended and Restated Credit Agreement dated July 31, 2023 (Exhibit 10.3)
All three amendments are dated February 4, 2025 and were filed with the 8-K on February 7, 2025
Valero Energy entered into an underwriting agreement on February 4, 2025, to issue $650 million of 5.150% senior notes due 2030 under a registered shelf. The sale is expected to close on February 7, 2025. The filing adds debt to the company's balance sheet, but it does not disclose how the proceeds will be used.
Principal amount: $650 million of 5.150% senior notes due 2030
Underwriters include Citigroup, BofA Securities, J.P. Morgan and Mizuho Securities as representatives
Cleveland-Cliffs issued $850 million of 7.500% senior guaranteed notes maturing September 15, 2031, in a private transaction, under an indenture dated February 6, 2025. The company intends to use the net proceeds for general corporate purposes, including repaying borrowings under its asset-based credit facility, which adds long-term debt while refinancing shorter-term borrowings.
Principal amount: $850 million; interest rate 7.500%, paid semi-annually on March 15 and September 15, starting September 15, 2025
Notes mature September 15, 2031; issued February 6, 2025 to U.S. Bank Trust Company, National Association, as trustee
Company may redeem before March 15, 2028 at par plus a make-whole premium, and from March 15, 2028 at an initial 103.750% price
Net proceeds intended for general corporate purposes, including repayment of asset-based credit facility borrowings
Allegro MicroSystems entered into Amendment No. 3 to its credit agreement, creating a new $375 million tranche of term loans maturing October 31, 2030. The proceeds will refinance existing Amendment No. 2 term loans, pay related fees and expenses, and fund general corporate purposes, so the company is replacing existing borrowing rather than announcing a new spending plan.
New $375 million term loan tranche maturing October 31, 2030
Loans amortize at 0.00% per annum and bear interest at Term SOFR plus 2.00%, or an alternate base rate option
Proceeds will refinance all outstanding Amendment No. 2 term loans, pay fees, and fund general corporate purposes
Amendment No. 3 dated February 6, 2025, filed as Exhibit 10.1
GATX agreed under an underwriting agreement dated February 4, 2025 to sell $500 million of 5.500% Senior Notes due 2035 and $300 million of 6.050% Senior Notes due 2054, with delivery against payment on February 6, 2025. The 2054 notes will form a single series with $400 million issued June 5, 2024, bringing the total outstanding 2054 notes to $700 million, which adds to the company's debt load.
$500 million of 5.500% Senior Notes due 2035 offered
$300 million of 6.050% Senior Notes due 2054 offered, fungible with $400 million issued June 5, 2024
Aggregate 2054 notes outstanding to total $700 million on completion
Notes issued under a 2008 indenture with U.S. Bank Trust Company, National Association, as trustee
Eagle Materials entered Amendment No. 2 to its unsecured credit agreement on February 4, 2025, with JPMorgan Chase Bank, N.A. as administrative agent. The new $300 million term loan A refinanced the existing $200 million term loan and partly repaid revolving loans, and the $750 million revolving facility was replaced, with both maturing February 4, 2030. The filing describes the terms as a refinancing and extension of existing borrowing capacity rather than a change in operations.
New senior unsecured term loan A of $300 million, fully drawn on February 4, 2025, replacing the $200 million existing term loan
New revolving facility of up to $750 million, replacing the existing revolver, with a $40 million letter of credit sub-facility and $25 million swingline sub-facility
Both the new term loan and revolver mature February 4, 2030, versus May 5, 2027 under the existing agreement
Uncommitted incremental facility of up to $375 million available under the credit agreement
VICI Properties L.P., a wholly owned subsidiary of VICI Properties Inc., entered into a new $2.5 billion senior revolving credit facility on February 3, 2025, replacing its existing facility that was due to mature March 31, 2026. The new facility extends the maturity to February 3, 2029, and borrowings under it were used to repay the existing facility. For shareholders, the filing shows a longer maturity runway and a larger potential commitment, with terms including interest margins, financial maintenance covenants and an option to increase commitments by up to $1.0 billion.
New $2.5 billion senior revolving credit facility with Wells Fargo Bank, N.A. as administrative agent, maturing February 3, 2029
Replaces existing $2.5 billion facility with JPMorgan Chase Bank, N.A. that was scheduled to mature March 31, 2026
About $147.5 million advanced under the new facility as of the effective date, used to repay existing obligations
Option to increase revolving commitments by up to $1.0 billion, for a total of $3.5 billion
Patterson-UTI Energy entered a Second Amended and Restated Credit Agreement on January 31, 2025, providing $500 million of committed senior unsecured revolving credit that matures January 31, 2030. The filing replaces the company's credit agreement dated March 27, 2018 and sets borrowing costs tied to its credit rating.
Facility commitments of $500 million, with a $100 million letter of credit sub-facility and a swing line sub-facility of up to $50 million
Maturity date of January 31, 2030; commitments may be increased by up to $200 million, to a maximum of $700 million, subject to conditions
SOFR loans priced at a margin of 1.25% to 2.25% plus a 0.10% adjustment, with the margin set by the company's credit rating
Financial covenants include a total debt to capitalization ratio not exceeding 50% at each fiscal quarter end
Adient Global Holdings, a wholly-owned subsidiary of Adient plc, entered into an indenture for $795 million of 7.500% senior unsecured notes maturing February 15, 2033. Proceeds, together with cash on hand, will redeem its 4.875% senior unsecured notes in full and pay related fees and expenses. The filing does not state the redeemed notes' total amount or any effect on Adient's earnings, but it adds new debt with a 7.500% coupon in place of 4.875% notes.
Notes: $795 million principal, 7.500% coupon, maturing February 15, 2033
Interest payable semi-annually on February 15 and August 15, starting August 15, 2025
Proceeds plus cash on hand to redeem 4.875% senior unsecured notes in full
Early redemption before February 15, 2028 requires a make-whole premium; change of control triggers a 101% repurchase offer
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.